Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Kamada Ltd. (KMDA) vs Alpha Teknova, Inc. (TKNO)

Kamada Ltd. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Kamada Ltd. and Alpha Teknova, Inc. are of similar size ($509.4M and $498.8M). Alpha Teknova, Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 22.9×. Kamada Ltd. grew revenue faster over the last twelve months: 13.2% against 12.3%. Kamada Ltd. has the higher net margin (11.6% vs −38.4%) and the higher return on invested capital (8.47% vs −16.9%). Across the 19 metrics below, Kamada Ltd. leads on 17 and Alpha Teknova, Inc. on 2.

Valuation

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
P/E 22.95 n/m 20.14
P/S 2.63 11.45 2.25
P/B 1.87 7.99 1.90
Price to free cash flow 19.18 n/m 16.54
EV/EBITDA 10.33 n/m 12.29
EV/Sales 2.32 11.45 2.56
Earnings yield 4.36% (3.32%) (2.99%)
Free cash flow yield 5.21% (1.47%) 0.00%

Profitability

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Gross margin 40.82% 34.60% 53.94%
Operating margin 14.51% (36.19%) 0.00%
Net margin 11.60% (38.37%) 0.00%
Free cash flow margin 13.72% (16.83%) 0.00%
Return on equity 8.40% (24.19%) (0.40%)
Return on assets 5.92% (16.25%) (3.32%)
Return on invested capital 8.47% (16.93%) 0.00%

Growth

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 13.17% 12.27% 10.01%
EPS growth (last fiscal year) 40.00% 43.86% —
Revenue growth, 5-year CAGR 6.25% 5.30% 6.74%
Net income growth, 5-year CAGR 3.34% 0.00% 0.00%

Health

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.02 0.21 0.05
Current ratio 4.06 4.49 2.31
Net debt to EBITDA (1.59) 0.75 0.85

Dividend

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Market cap 509.40m 498.76m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack